Adia Nutrition, Inc.
corporate_fare Company Profile
Adia Nutrition, Inc. (OTC:ADIA) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 6 items for ADIA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-13, rated 8/10. Across its 6 most recent items scored 7 or higher, the top rating is 9/10, with 6 rated 8 or above. Recent SEC coverage for ADIA spans 10-Q, 10-K.
Recent high-impact activity:
- Adia Nutrition Q2 2026: Going Concern Warning, Ineffective Controls, and New Preferred Issuance
- Adia Nutrition Secures Expanded Stem Cell Coverage for 250,000+ Members Through Health Care Sharing Ministry
- Adia Nutrition Reports Worsening Losses, Going Concern Warning, and Ineffective Controls; Omits Recent Positive News
- Adia Nutrition's Groundbreaking Kidney Disease Stem Cell Study Receives IRB Approval, Nears Patient Enrollment
- Adia Nutrition Partners for 100-Patient Autism Study, Supplying 300 High-Value Regenerative Infusions
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 460 shares in ADIA as of the September 15, 2026 settlement, unchanged from the prior period — about 1.0 days to cover at its recent average daily volume. On October 2, 2026, 42.5% of ADIA volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.